Explore By Subject Area   
Return Home
Register Here Menu

Immuno-Oncology 360°

Date: Feb 10, 2026 - Feb 12, 2026

Location: Boston, MA

Day One: Tuesday, February 10, 2026
Showing Events in 1 Track from 07:30am to 08:10am
Registration & Morning Remarks
Grand Ballroom
7:30AM - 8:00AM
Registration
8:00AM - 8:10AM
IO360° Opening Remarks
Co-chairs:
James Gulley, MD, PhD, FACP, Co-Director, Center for Immuno-Oncology, CCR & Clinical Director, National Cancer Institute, NIH
Axel Hoos, MD, PhD, Former CEO, Scorpion Therapeutics
Showing Events in 1 Track from 08:15am to 09:05am
Opening Keynote
Grand Ballroom
8:15AM - 8:25AM
Presenting the IO360° Lifetime Achievement Award
Presented by:
Theresa LaVallee, PhD, Chief Scientific & Development Officer, Coherus Oncology
8:25AM - 8:50AM
Keynote: Checkpoint Blockade and Beyond: Charting the Next Era of Immuno-Oncology
Keynote Speaker:
Jedd Wolchok, MD, PhD, Meyer Director of the Sandra and Edward Meyer Cancer Center and Professor of Medicine, Weill Cornell Medicine
8:50AM - 9:05AM
Immunotherapy Through the Eyes of Patient and Physician
Fireside Guests:
Brendan Connors, Patient, Advocate
Jedd Wolchok, MD, PhD, Meyer Director of the Sandra and Edward Meyer Cancer Center and Professor of Medicine, Weill Cornell Medicine
Showing Events in 1 Track from 09:05am to 09:25am
New Technologies in Transformational Biology
9:05AM - 9:25AM
Beyond Cytotoxicity: Granzyme B ADCs – A New Paradigm in Immuno-Oncology Payload Discovery
Speaker:
Claire Thuning-Roberson, PhD, CEO, AbBC Therapies
Showing Events in 1 Track from 09:25am to 10:05am
Grand Opening of the IO360° Networking Café
Grand Ballroom Foyer
9:25AM - 10:05AM
Grand Opening of the IO360° Networking Café
Showing Events in 1 Track from 10:05am to 11:00am
New Technologies in Transformational Biology (Continued)
Grand Ballroom
Plenary Chair:
James Gulley, MD, PhD, FACP, Co-Director, Center for Immuno-Oncology, CCR & Clinical Director, National Cancer Institute, NIH
10:05AM - 10:25AM
AstraZeneca’s Bet on In Vivo CAR-T: A Preclinical Perspective
Speaker:
Philippe Parone, PhD, Head, Cell Therapy In Vivo / CSO, AstraZeneca / EsoBiotec
10:25AM - 10:45AM
Antisense Oligonucleotides (ASOs) for Cancer: Why This Modality’s Moment Has Arrived
Speaker:
Zdravka Medarova, PhD, CSO & Co-founder, TransCode Therapeutics
10:45AM - 11:00AM
Reserved for BD Biosciences
Showing Events in 1 Track from 11:00am to 11:10am
10 Min Health Break
11:00AM - 11:10AM
10 Min Health Break
Showing Events in 1 Track from 11:10am to 12:20pm
Morning Tracks
11:10AM - 12:20PM
Two Track Choices: IO Novel Technologies Showcase
Participating Companies:
Showing Events in 2 Tracks from 11:10am to 12:00pm
TRACK 1: IO Novel Tech Showcase A
Grand Ballroom
11:10AM - 11:20AM
Picture Health
Speaker:
Brian Kelly, Chief Commercial Officer, Picture Health
11:20AM - 11:30AM
Radiomics
Speaker:
Wim Vos, PhD, CEO, Radiomics.bio
11:30AM - 11:40AM
RareCyte
Speaker:
Jeff Chamberlain, PhD, Director, Biopharma Partnerships, RareCyte
11:40AM - 11:50AM
Ozette Technologies, Inc
Speaker:
Mike Comeau, Director, Scientific Alliances, Ozette Technologies, Inc.
11:50AM - 12:00PM
Open Session
TRACK 2: IO Novel Tech Showcase B
Constitution Ballroom AB
11:10AM - 11:20AM
TD2 Oncology
Speaker:
Jennifer Stewart, PhD, VP, Flow Cytometry Strategy, TD2
11:20AM - 11:30AM
RoukenBio
Speaker:
Matt Freer, Senior BD Manager, RoukenBio
11:30AM - 11:40AM
GenoBioTX
Speaker:
Derek Reznik, PhD, BD Manager, GenoBioTX
11:40AM - 11:50AM
Open Session
11:50AM - 12:00PM
Open Session
Showing Events in 2 Tracks from 12:20pm to 01:35pm
Lunch and Networking
Networking & Exhibits: Grand Ballroom Foyer / 1:1 Partnering Meetings: Back Bay AB
12:20PM - 1:35PM
Lunch & 1:1 Partnering Meetings Begin
Women's Luncheon
Republic Ballroom
12:20PM - 1:35PM
3rd Annual Women Leaders in IO Panel & Luncheon
Moderator:
Marisa Dolled-Filhart, PhD, Global Team Lead, Early Oncology; Asset and Portfolio Management, Daiichi Sankyo US
Panelists:
Theresa LaVallee, PhD, Chief Scientific & Development Officer, Coherus Oncology
Julie Martin, MSc, MBA, President & CEO, Scimega Research
Barbra Sasu, PhD, CSO, Dispatch Bio
Showing Events in 2 Tracks from 01:40pm to 03:20pm
TRACK 1: New Tech in Transformational Biology
Grand Ballroom
1:40PM - 2:00PM
AI-Driven Protein Design: The Next Frontier in TCR-Based Immuno-Oncology
Speaker:
John Connolly, PhD, CSO, Parker Institute for Cancer Immunotherapy (PICI)
2:00PM - 2:20PM
Next-Generation Cancer Vaccines: Mining the Dark Genome for Novel Shared Antigens
Speaker:
Jon Moore, PhD, CSO, Epitopea
2:35PM - 2:55PM
Cytokine-Based ADCs: IL-12 and IL-18 as Immune-Modulating Payloads
2:55PM - 3:15PM
CAR-DCs to Improve Antitumor Immunity
Speaker:
Carl DeSelm, MD, PhD, Assistant Professor, Radiation Oncology & Principle Investigator, Washington University in St. Louis
TRACK 2: Imaging-Driven Innovation in IO
Constitution Ballroom AB
1:40PM - 2:00PM
The Imaging Reality Check: Practical Insights from a Leading IO Trialist
Speaker:
Diwakar Davar, MD, Associate Professor, Clinical Director, Melanoma and Skin Cancer Program, UPMC Hillman Cancer Center
2:00PM - 2:40PM
Panel: Imaging Lessons from IO 1.0 to Shape IO 2.0: From Smarter Design to Meaningful Impact
Moderator:
Antonio "Tito" Fojo, MD, Professor of Medicine / Co-Director, Columbia Adrenal Surgery Center, Columbia University Medical Center
Panelists:
Susan E. Bates, MD, Professor of Medicine / Director, Translational Cancer Medicine, Columbia University Medical Center
Jack Hoppin, PhD, Chairman, Chief Executive Officer, Ratio Therapeutics
David Leung, MD, PhD, Head of Imaging, Daiichi Sankyo
2:40PM - 3:20PM
Panel: Measuring What Matters: Using Biomarkers to Guide Patient Selection and Treatment in IO
Moderator:
Ryan Hartmaier, PhD, Sr Director, Translational Medicine, Oncology R&D, AstraZeneca
Panelists:
Gregory Frank, PhD, Global Scientific Partnering Strategy, Immuno-Oncology, GE HealthCare
Greg Goldmacher, MD, PhD, MBA, Associate VP, Clinical Research; Head, Clinical Imaging & Pathology, Merck Research Laboratories
Catherine Hines, PhD, Executive Director and Head, Clinical Imaging, GSK
Dejan Knezevic, PhD, Senior Director, Bio Pharma Business Development, Natera
Showing Events in 1 Track from 03:25pm to 04:05pm
Afternoon Networking Break
Networking & Exhibits: Grand Ballroom Foyer / 1:1 Partnering Meetings: Back Bay AB
3:25PM - 4:05PM
Afternoon Networking Break and Partnering Meetings
Showing Events in 2 Tracks from 04:10pm to 05:45pm
TRACK 1: Breakthroughs in Translational Science Part 1
Grand Ballroom
4:10PM - 4:30PM
RIPTAC: A New Frontier in Targeted Protein Degradation – Insights from J&J
Speaker:
Charles Drake, MD, PhD, VP, Immuno-Oncology, J&J Innovative Medicine
4:30PM - 4:50PM
What Drives an Effective Anti-Tumor Immune Response? Insights from Blood-Borne and Solid Tumors
Speaker:
Erik Manting, PhD, CEO, Mendus
4:50PM - 5:05PM
Reserved Session
5:05PM - 5:25PM
Targeting IL-27 to Activate Antitumor Immunity: Insights from Casdozokitug
Speaker:
Sruthi Ravindranathan, PhD, Senior Scientist, Translational Medicine, Coherus Oncology
5:25PM - 5:45PM
Learnings from VG161: Reprogramming Immunity Through Oncolytic Virotherapy
Speaker:
William Jia, PhD, CSO & Co-founder, Virogin Biotech
TRACK 2: Imaging-Driven Innovation in IO
Constitution Ballroom AB
4:10PM - 4:30PM
Understanding, Detecting and Harnessing Immunogenic Cell Death in IO
Speaker:
Lorenzo Galluzzi, PhD, Associate Professor Cancer Signaling and Microenvironment Research Program, Fox Chase Cancer Center, Temple Health
4:30PM - 5:10PM
Panel - From Hype to Impact: Where AI in Imaging Is Moving the Needle in IO Development
Moderator:
Greg Goldmacher, MD, PhD, MBA, Associate VP, Clinical Research; Head, Clinical Imaging & Pathology, Merck Research Laboratories
Panelists:
Diederik Grootendorst, PhD, Director, Global Oncology Imaging, Bristol Myers Squibb
Petr Jordan, PhD, CTO, Onc.AI
Jayant Narang, MD, Sr Medical Director, Clinical Oncology Imaging Lead, Preclinical and Translational Sciences, Takeda Pharmaceuticals
5:10PM - 5:40PM
Improving Tumor Assessment Using Growth Dynamics
Speakers:
Susan E. Bates, MD, Professor of Medicine / Director, Translational Cancer Medicine, Columbia University Medical Center
Antonio "Tito" Fojo, MD, Professor of Medicine / Co-Director, Columbia Adrenal Surgery Center, Columbia University Medical Center
Showing Events in 1 Track from 05:50pm to 06:50pm
12th Annual Networking Reception
Grand Ballroom Foyer
5:50PM - 6:50PM
12th Annual Networking Reception & 1:1 Partnering Meetings
Previous
Day One
Tuesday, February 10, 2026

Subscribe for More Information

Please provide your contact information and select areas of interest to receive updates.